Neoantigens, are derived from random somatic mutations in cancer cells and are not present in healthy cells. Therefore, not only can you target them due to there being no pre-existing tolerance, but also there is very little risk of inducing autoimmunity [1-3].
In humans, there is a large amount of evidence showing that T-cells, which target these serve an important role in mediating clinical responses to a range of different immunotherapies such as anti-PD-1 mAbs [4].
However, two of the biggest challenges are identification and delivery. When it comes to the latter, the company is using a heterologous prime-boost regime [5]. The hope is by using this they are able to generate enough T-cells to impact the cancer. For the former they have their own platform (EDGE). It was tested against public methods as well as how both compared to another approach used by Dr. Rosenberg/NCI. The majority (19/26, 73%) of MHC Class I restricted neoantigens would be included with EDGE vs. only 9/26 (35%) with public tools [6]. They will try to prioritise clonal over subclonal neoantigens [7]. Last year a collaboration with BLUE happened and this somewhat helps with validation in my view [8].
Refs:
1 https://www.cell.com/trends/molecular-medicine/fulltext/S1471-4914(17)30147-8
2 https://science.sciencemag.org/content/348/6230/69.long
3 https://www.nature.com/articles/nature13988
4 https://www.nature.com/articles/nature13954
5 http://cancerres.aacrjournals.org/content/78/13_Supplement/724
6 https://www.nature.com/articles/nbt.4313
7 https://science.sciencemag.org/content/351/6280/1463
8 https://www.businesswire.com/news/home/20180823005039/en/bluebird-bio-Gritstone-Oncology-Announce-Strategic-Collaboration
Recent GRTS News
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/13/2024 08:10:52 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/13/2024 08:08:56 PM
- Gritstone bio Reports Second Quarter 2024 Financial Results and Provides Corporate Updates • GlobeNewswire Inc. • 08/13/2024 08:05:00 PM
- Lost Money on Gritstone bio, Inc.(GRTS)? Join Class Action Suit Seeking Recovery - Contact The Gross Law Firm • PR Newswire (US) • 08/05/2024 09:45:00 AM
- Lost Money on Gritstone bio, Inc. (GRTS)? Join Class Action Suit Seeking Recovery - Contact The Gross Law Firm • PR Newswire (US) • 08/05/2024 09:45:00 AM
- Gritstone bio, Inc. Sued for Securities Law Violations - Investors Should Contact The Gross Law Firm Before August 6, 2024 to Discuss Your Rights - GRTS • PR Newswire (US) • 07/25/2024 09:45:00 AM
- Gritstone Bio Inc Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - GRTS • PR Newswire (US) • 07/25/2024 06:38:00 AM
- Gritstone bio to Host Virtual KOL Event to Discuss Unmet Need and Potential Role of Its Personalized Cancer Vaccine, GRANITE, in Metastatic Microsatellite Stable Colorectal Cancer (MSS-CRC) • GlobeNewswire Inc. • 07/24/2024 11:00:00 AM
- The Gross Law Firm Notifies Shareholders of Gritstone bio, Inc.(GRTS) of a Class Action Lawsuit and an Upcoming Deadline • PR Newswire (US) • 07/17/2024 09:45:00 AM
- The Gross Law Firm Notifies Shareholders of Gritstone bio, Inc.(GRTS) of a Class Action Lawsuit and an Upcoming Deadline • PR Newswire (US) • 07/17/2024 09:45:00 AM
- Lost Money on Gritstone bio, Inc.(GRTS)? Join Class Action Suit Seeking Recovery - Contact The Gross Law Firm • PR Newswire (US) • 07/12/2024 09:45:00 AM
- Gritstone bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) • GlobeNewswire Inc. • 07/10/2024 11:00:00 AM
- Gritstone Bio Inc Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - GRTS • PR Newswire (US) • 07/04/2024 06:14:00 AM
- Gritstone bio, Inc. Class Action: The Gross Law Firm Reminds Gritstone Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of August 6, 2024 - GRTS • PR Newswire (US) • 07/03/2024 09:45:00 AM
- The Gross Law Firm Notifies Shareholders of Gritstone bio, Inc.(GRTS) of a Class Action Lawsuit and an Upcoming Deadline • PR Newswire (US) • 06/28/2024 09:45:00 AM
- Shareholders that lost money on Gritstone bio, Inc.(GRTS) should contact The Gross Law Firm about pending Class Action - GRTS • PR Newswire (US) • 06/25/2024 09:45:00 AM
- Shareholders that lost money on Gritstone bio, Inc.(GRTS) Urged to Join Class Action - Contact The Gross Law Firm to Learn More • PR Newswire (US) • 06/20/2024 09:45:00 AM
- The Gross Law Firm Reminds Gritstone bio, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of August 6, 2024 - GRTS • PR Newswire (US) • 06/17/2024 09:45:00 AM
- Gritstone bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) • GlobeNewswire Inc. • 06/13/2024 11:00:00 AM
- Gritstone bio to Participate in Upcoming Investor and Scientific Conferences • GlobeNewswire Inc. • 06/04/2024 08:05:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/18/2024 01:57:57 AM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM
Element79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership • ELMGF • Sep 18, 2024 10:29 AM
Mawson Finland Limited Further Expands the Known Mineralized Zones at Rajapalot: Palokas step-out drills 7 metres @ 9.1 g/t gold & 706 ppm cobalt • MFL • Sep 17, 2024 9:02 AM
PickleJar Announces Integration With OptCulture to Deliver Holistic Fan Experiences at Venue Point of Sale • PKLE • Sep 17, 2024 8:00 AM